News and press

Swiss pharmaceutical company licensed Göttingen cell lines

Göttingen 10.08.2011

Göttingen technology transfer organization MBM ScienceBridge GmbH succeeded in closing a license deal for antibody-producing cell lines with an international company - the Swiss pharmaceutical company F. Hoffmann-La Roche Ltd. The cell lines derived from the Department of Immunology of the Göttingen Universitätsmedizin is a further example of successful commercialization of research materials from antibody research.

The scientists led by Professor Martin Oppermann of the Department of Immunology, Georg-August-University Göttingen mainly work on the physiological and pathological functions of the complement system, an integral part of the body's immune system and have developed a variety of monoclonal antibodies and cell lines against factors of complement system in the last years, which are used for research purposes, but also find applications in the development of diagnostic tests and therapeutic solutions.

read more

BalanceBoard – Wood is replaced by annually-regenerating fibrous plants

Göttingen/Neumarkt 02.02.2011

Göttinger scientists at the faculty of forestry and Pfleiderer AG developed an innovative composite. MBM ScienceBridge, the technology transfer organisation of the University of Göttingen, successfully negotiated the license agreement between the University of Göttingen and Pfleiderer, one of the world's leading manufacturers of engineered wood. BalanceBoard has been now successfully introduced to the market at the fair BAU 2011 in Munich.

Göttingen/Neumarkt, 28th January 2011 - During the BAU 2011 exhibition Pfleiderer AG will be presenting their new material for the first time - BalanceBoard. With up to 30 per cent made up of raw material which grows back quickly in place of wood, BalanceBoard is really setting the benchmark for sustainability, processability and security of supply.

read more

Looking for innovation

A subsidiary of

Georg-August-Universität Göttingen